Efficacy of autologous mesenchymal stromal cell treatment for chronic degenerative musculoskeletal conditions in dogs: A retrospective study.

There is an argument that the same would not apply to judging QOL impact, since the clinician does not see the dog in its home environment, but the result of the analysis was remarkably similar with highly significant time window effects ( p < 0.001) and all post-treatment means were significantly lower than pre-treatment.

also in 132,142 other papers